Showing results (21-30 of 394) with videos related to
Sort By:
Pageof 40
Scientifica|July 24, 2014
Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancerRizwan Romee, Jeffrey W Leong, Todd A FehnigerCurrent Opinion in Hematology|May 18, 2010
Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cellsIskra Pusic, John F DiPersioCurrent Hematology Reports|June 26, 2004
Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options?Vikram Mathews, John F DiPersioTherapeutic Advances in Hematology|February 3, 2016
Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidenceArmin Rashidi, John F DiPersioFrontiers in Immunology|September 20, 2024
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insightsAlaa Ali, John F DiPersioCurrent Opinion in Organ Transplantation|September 29, 2015
Improving natural killer cell cancer immunotherapyMelissa M Berrien-Elliott, Rizwan Romee, Todd A FehnigerLeukemia Research|October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDSEric Huselton, Michael P Rettig, Kirsten Campbell, et al.Blood Reviews|November 15, 2017
Diabetes mellitus as a poor mobilizer conditionGian Paolo Fadini, John F DiPersioPageof 40